文档介绍：AbstractOxaliplatinpolylacticacidnanoparticles(OP—PLANPs)andoxaliplatinpoly(ethyleneglyc01)一poly(1actide)nanoparticles(OP—PEG-PLANPs)—acid(PLA)andpoly(ethyleneglyc01)一poly(1actide)(PEG—PLA)areemployedasvectors/(DL)andentrapmentefficiency(EE),theoptimumtechnologicalparametersfornanopaticlespreparationswereasfollows:theratioofdrugtovectors/carriers1::%andcarrierconcentration20mg/-(+)%,()%and(+)%,(+)%(TEM)observationindicatedthatthenanoparticlesweresphere--likeentitieswithasmoothandnon-·—PLANPsandOP—PEG-,,PLANPsandPEG-PLANPssolutionintorabbitauricularvein,,1,2,4,8,12,24and48hwasdeterminedviaICP-,OPconcentration—partmentmodelwithweightedindexof1/-PLANPsgroupwereasfollows:tl/,tl/213=,AUC=‘h,CL=/(gg/m1)andtl/2a=,t11213=17。18h,AUC=‘h,CL=/(;.tg/m1).Meanwhile,themajorcalculatedparametersoftheOP--PEG—·PLANPsgroupwereasfollows:t1/,tlnl5=,AUC=‘h,andCL=/(gg/m1).TheanalyticresultsshowedthatPLANPsandPEG—PLANPswereabletoextendtheretentiontimeofOPinrabbits,increasetheAUCandreducetheCLsignificantly,indicatedthatOP-PEG—PLANPsCanimprovethebioavailabilityofOP,,PLANPsandPEG—PLANPssolutionintoS80tumor-bearin